Principal Scientist, Early DCT Lead
Merck & Co., Inc. - USA - New Jersey - Rahway
Posted Nov 6, 2026
Benefits
- Parental leave
- Not verified
- Non-birth-parent leave
- Not verified
- Family-building benefits
-
- Fertility benefits: Not verified
- Adoption assistance: Not verified
- Surrogacy assistance: Not verified
- Mental health support
- Not verified
- Relocation assistance
- Not verified
- Childcare support
- Not verified
- Learning budget
- Not verified
- Verification
- Not verified checked Nov 20, 2026
- Salary
- $173K-$273K From the posting source checked Nov 16, 2026
- 401(k) match
- Reported from DOL Form 5500 industry filing (not employer-specific)
Was this benefit information wrong? Tell us.
Role
- Seniority
- Principal From the posting source checked Nov 16, 2026
Schedule
- Shift type
- Not verified
- Weekend work
- Not verified
Company
- Equity
- Offered Verified - SEC 10-K source checked Nov 16, 2026
Application
- Cover letter
- Not verified
- Assessment
- Not verified
- Deadline
- Not stated
Where they hire
State eligibility is not yet verified.
About this role
Principal Scientist, Early DCT Lead USA - New Jersey - Rahway Job Description The Sterile Product Development (SPD) group is responsible for developing non-oral dosage forms, including injections, implants, inhaled and ocular products, for small, intermediate and large molecules from preclinical toxicology studies through commercialization. Our development teams ensure robust formulation, primary packaging/device, process and manufacturing strategies through deep scientific understanding and characterization, enabling scalable development plans without compromising stability, safety, efficacy or delivery. During development, we leverage smart experimental design, cutting-edge analytical tools and predictive approaches to inform molecule, formulation and process selection. In summary, our team enables the translation of preclinical candidates into non-oral drug products. Our team is seeking an accomplished, highly collaborative scientific and matrix leader for a Principal Scientist (R5) - Development and Commercialization Team (DCT) Leader position at our research facility in Rahway, New Jersey. As an Early-Stage DCT Leader, you will provide strategic, technical, and operational direction for integrated CMC teams, advancing a portfolio of pipeline biologics from candidate selection through early clinical development and First-in-Human (FIH) milestones, while laying the groundwork for commercialization. The candidate is expected to have biologics product development experience and will continue to support relevant drug product activities, combined with broad working-knowledge of end-to-end CMC disciples and a proven ability to lead matrixed teams with an enterprise, “robustness at launch” mindset. The ideal candidate bridges enterprise matrix leadership with rigorous technical acumen, demonstrating a proven track record of driving cross-functional alignment, managing program risk, and championing scientific excellence.
Read the full description at msd.wd5.myworkdayjobs.com. FewerJobs shows a preview and links to the original posting.
Apply link verified; last checked Nov 20, 2026.
What verified means
Verified means a displayed claim has field-level provenance to a source FewerJobs pulled: a government or employer source, or the original job posting. Posting-sourced facts are employer-stated and are labeled separately from government records.
Related jobs
Principal Scientist, Early DCT Lead
Merck & Co., Inc. - USA - New Jersey - Rahway
Principal Scientist, Chemical Development
Immunome Inc - Bothell, Washington, United States
Principal Scientist I, PDS&T Analytical CMC Development
AbbVie Inc. - Worcester, MA, United States
Associate Principal Scientist, Vaccine Drug Product Development
AstraZeneca - US - Gaithersburg - MD